Inventory of 56 medical and health companies that are sprinting IPO

The big health industry has become the world's largest emerging industry in recent years. In China, the "Healthy China 2030" Plan Outline clearly sets out the future scale of the health service industry - to reach 8 trillion by 2020 and 16 trillion by 2030. Obviously, medical health will continue to receive capital attention for a long time in the future, and the contribution of capital is one of the strong driving forces for the development of the industry.

From the following data, we can get a glimpse of the listed health care companies (data source is Wonder):

At present, there are 79 listed companies in the “health care” category, with a median market value of 3.392 billion yuan. The median value of operating income in 2016 was 502 million yuan, and the median net profit was 46.67 million yuan.

There are 33 listed companies in the category of “medical and medical equipment wholesale”, with a median market value of 4.378 billion yuan. The median value of operating income in 2016 was 207 million yuan, and the median net profit was 86.84 million yuan.

There are 198 listed companies in the “pharmaceutical” category, with a median market value of 5.965 billion yuan. The median operating income in 2016 was 9.99 billion yuan, and the median net profit was 125 million yuan.

The health care companies that are sprinting IPOs are also hot. As of May 18, the 569 start-up enterprises accepted by the China Securities Regulatory Commission had 56 medical and health industries, including 28 main boards, 11 small and medium-sized boards, and 17 GEM.

The company to be reviewed needs to pass the process of the CSRC's acceptance-feedback-pre-disclosure update-over-meeting. Among the 56 medical health-related enterprises, 7 companies are in the acceptance stage, 31 companies are in the feedback stage, 8 companies are in the pre-disclosure update stage, 5 companies have passed the examination, and 1 company has been issued. The trial was suspended and the four companies were suspended for review. (May 24th information update: Shenzhen Huada Gene has passed the examination.)

Below, a list of the review status of all queued companies, the subdivisions they belong to, and the details of the suspension review companies are listed.

Note: The “*” is the first company to be audited in the 12 provinces, cities and counties in the west.

Among them, there are 34 pharmaceutical-related enterprises (pharmaceuticals, pharmaceutical raw materials, pharmaceutical retail, pharmaceutical packaging, etc.), accounting for nearly 60% of the total. Other areas include medical equipment , medical materials, nutrition and health care, hospitals, and genetics.

Electric Operating Table

Electric Operating Table Adopt imported TIMOTION electric push rod as the power source for the operation tables. Adopt German imported STABILUS as the power source of the operation beds; Operation beds adopt medical grade 304# full stainless steel materials; Full set of micro electric control system for ot table with low noise, overload protection, safty reliablity; TheElectric Operating Table entire table of operating table can move forward and backward to realize full position C-arm and X-ray radiography;

Electric Operation Table,Electric OT Table,Electric Surgery Table,Electric Surgical Table

Shandong Lewin Medical Equipment Co., Ltd. , https://www.lewinmed.com